Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
67 institutional managers report a position in Drugs Made In America Acquisition II Corp. worth $449.2M between them, filed on form 13F for the quarter ending 2026-06-30. 26 of them hold 80% of it, the largest being Karpus Management, Inc. at 6.24%.
42 more managers in the register
26 managers hold 80% of the $449.2M institutional base. The other 41 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
DMII (Drugs Made In America Acquisition II Corp.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Drugs Made In America Acquisition II Corp.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Blank Checks
Prev close 10.18 · gapped below the open, never looked back. High/low 10.18 at 3:00 pm ET, 10.16 at 3:15 pm ET.
via Magnetar Financial LLC, Glazer Capital, LLC, Karpus Management, Inc. +32 more · 6.05% of DMII, 5.66% of OBA
via Highbridge Capital Management LLC, Glazer Capital, LLC, Hudson Bay Capital Management LP +25 more · 5.02% of DMII, 6.06% of APXT
via Highbridge Capital Management LLC, Glazer Capital, LLC, MMCAP International Inc. SPC +31 more · 5.02% of DMII, 5.23% of MBVI
via Karpus Management, Inc., Glazer Capital, LLC, Magnetar Financial LLC +28 more · 6.24% of DMII, 8.70% of FIGX
via MMCAP International Inc. SPC, Glazer Capital, LLC, Hudson Bay Capital Management LP +26 more · 6.05% of DMII, 5.22% of MESH
via Magnetar Financial LLC, Glazer Capital, LLC, MMCAP International Inc. SPC +30 more · 6.05% of DMII, 6.33% of ITHA
Managers holding a meaningful stake in DMII also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.